Zalutumumab

Zalutumumab Uses, Dosage, Side Effects, Food Interaction and all others data.

Zalutumumab is a fully human IgG1 monoclonal antibody designed to bind with selectivity to the epidermal growth factor receptor (EGFR). Zalutumumab has been investigated for the treatment of Squamous Cell Cancer and Head and Neck Cancer.

Trade Name Zalutumumab
Generic Zalutumumab
Zalutumumab Other Names Zalutumumab
Type
Formula C6512H10074N1734O2032S46
Weight 146641.0546 Da
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Zalutumumab
Zalutumumab

Innovators Monograph

You find simplified version here Zalutumumab

*** Taking medicines without doctor's advice can cause long-term problems.
Share